Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.04.14	WDH/ROUNDUP: Botox-Hersteller Allergan greift zu 'Giftpille' (dpa-afx)
23.04.14	Botox-Hersteller Allergan greift zur 'Giftpille' wegen Valeant-Offerte (AWP)
23.04.14	ROUNDUP: Botox-Hersteller Allergan greift zur 'Giftpille' wegen Valeant-Offerte (dpa-afx)
23.04.14	Botox-Hersteller Allergan greift zur 'Giftpille' wegen Valeant-Offerte (dpa-afx)
23.04.14	Botox-Hersteller Allergan greift zur "Giftpille" wegen Valeant-Offerte (AWP)
22.04.14	Kanadische Valeant bietet Milliarden für Botox-Hersteller (AWP)
22.04.14	Valeant Submits Merger Proposal To Allergan; Lifts FY Outlook - Quick Facts (RTTNews)
22.04.14	Valeant, Bill Ackman Consider Buying Valeant; Shares Surge (RTTNews)
21.04.14	After-market Movers For April 21 (NFLX, AGN, VRX, RMBS) (RTTNews)
27.02.14	Valeant Pharma Turns To Profit In Q4; Backs 2014 Cash EPS View - Quick Facts (RTTNews)
04.02.14	DXCM Gets FDA Nod, MRK Breathes Easy, Neovasc Takes Heart, VRX Opens Wallet (RTTNews)
31.01.14	Valeant Pharma Gets FDA Nod For SNDA For Retin-A Micro Gel Microsphere 0.08% (RTTNews)
22.01.14	Valeant Pharma Board Approves New $1.5 Bln Securities Buyback Program (RTTNews)
15.01.14	Valeant Receives Antitrust Clearance For Acquisition Of Solta Medical (RTTNews)
31.10.13	Valeant Pharma Posts Q3 Loss On Charges - Quick Facts (RTTNews)
29.10.13	INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch (RTTNews)
28.10.13	Valeant Pharma To Pay Anacor $142.5 Mln To Settle All Outstanding Litigation (RTTNews)
18.10.13	Valeant Pharmaceuticals Announces Award In Anacor Dispute (PR Newswire)
16.10.13	Anacor Awaits Arbitration Ruling (RTTNews)
15.10.13	Collaborations, Survey Results, Appointments, and Approvals - Research Report on Merck, Aetna, HCA, Medtronic, and Valeant Pharmaceuticals (PR Newswire)
07.10.13	Partnerships, Product Recall, New Contracts, Promotions, and Stock Movement - Research Report on Valeant, CareFusion, Envision Healthcare, Seattle Genetics, and Osiris (PR Newswire)
03.10.13	Valeant Gets FDA Marketing Clearance For Silicone Hydrogel Contact Lenses (RTTNews)
03.10.13	Valeant Pharmaceuticals' Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens (PR Newswire)
03.10.13	Valeant Pharmaceuticals Announces Approval Of Jublia® For The Treatment Of Onychomycosis In Canada (PR Newswire)
27.09.13	Under AAAResearchReports.com Microscope: Zoetis Inc., Teva Pharma Industries Ltd, Covidien PLC, and Valeant Pharma Intl. Inc. (PR Newswire)
21.08.13	Technical Study: Zoetis Inc., Teva Pharma Industries Ltd, Covidien plc, and Valeant Pharma Intl. Inc. (PR Newswire)
12.08.13	Financial Results Release, Management Changes, and Newly Issued Permits - Research Report on Valeant, Teva, Endo, Array, and Sequenom (PR Newswire)
10.08.13	Valeant Pharmaceuticals Announces Continuance (PR Newswire)
07.08.13	Valeant Pharma Posts Quarterly Profit, Lifts Full-year Earnings View Yet Again (RTTNews)
07.08.13	Valeant Pharma Posts Profit In Q2 - Quick Facts (RTTNews)
07.08.13	Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results (PR Newswire)
23.07.13	FDA Designations to Development Programs and Quarterly Financial Results Schedules - Research Report on Valeant, Elan, Alkermes, Teva and Gilead (PR Newswire)
27.05.13	Valeant Pharmaceuticals bietet Milliarden für Kontaktlinsenspezialist (AWP)
24.05.13	Valeant Pharma dürfte Bausch & Lomb für neun Milliarden Dollar kaufen (Kreise) (AWP)
28.04.13	PRESSE/Valeant und Actavis in Übernahmegesprächen (AWP)
31.07.07	Valeant Pharmaceuticals Announces Full Enrollment of First Retigabine Phase 3 Epilepsy Study (Businesswire)
18.07.06	Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients (Businesswire)
13.07.06	Valeant Pharmaceuticals to Announce 2006 Second Quarter Results on August 3, 2006 (Businesswire)
28.11.05	Valeant Pharmaceuticals Agrees to Acquire Rights to Hep-C Drug Infergen(R) from InterMune (Businesswire)
04.08.05	Valeant Pharmaceuticals Reports Second Quarter 2005 Results; Revenues Increase 20 Percent; Product Sales Advance 22 Percent (Businesswire)
02.02.05	Valeant Pharmaceuticals Proposes Public Offering of Common Stock (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	535.20	0.79 %	K V
Novartis	92.63	0.76 %	K V
Alcon	77.96	0.44 %	K V
Roche Hldg G	252.40	0.40 %	K V
Swisscom	506.00	0.40 %	K V
CieFinRichemont	121.75	-0.49 %	K V
UBS Group	27.55	-0.76 %	K V
ABB	48.97	-1.15 %	K V
Sika	225.70	-1.27 %	K V
Logitech Intl	70.12	-2.58 %	K V

mehr

Valeant Pharmaceuticals International Peer Group Nachrichten

07.06.16		Pharmakonzern Valeant kommt nicht zur Ruhe
20.08.15		Valeant kauft Hersteller von 'Viagra für Frauen'
23.02.15		Pharmakonzern Valeant will Rivalen Salix kaufen

07.06.16

Pharmakonzern Valeant kommt nicht zur Ruhe

20.08.15

Valeant kauft Hersteller von 'Viagra für Frauen'

23.02.15

Pharmakonzern Valeant will Rivalen Salix kaufen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Valeant Pharmaceuticals International

Aktien Top/Flop

Valeant Pharmaceuticals International Peer Group Nachrichten

Meistgelesene Nachrichten